People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

44.94USD
25 Jul 2014
Price Change (% chg)

$-0.77 (-1.68%)
Prev Close
$45.71
Open
$45.19
Day's High
$45.89
Day's Low
$44.76
Volume
399,288
Avg. Vol
761,687
52-wk High
$54.25
52-wk Low
$29.36

Search Stocks

Bloom, Floyd 

Brief Biography

Dr. Floyd E. Bloom is an Independent Director of Alkermes Plc. Dr. Bloom is a founder of Alkermes, Inc. and from 1987 to September 16, 2011 served on Alkermes' board of directors. Dr. Bloom has been active in neuropharmacology for 35 years, holding positions at Yale University, the National Institute of Mental Health and The Salk Institute. From 1983 to February 2005, Dr. Bloom was the Chairman of the Neuropharmacology Department at The Scripps Research Institute and Professor Emeritus. Dr. Bloom served as Editor-in-Chief of Science from 1995 to May 2000. He is a member of the National Academy of Science, the Institute of Medicine, the Royal Swedish Academy of Science, Veteran's Administration—Gulf War Veterans Illness Research and the Washington University Board of Trustees. Dr. Bloom is a director of LZ Therapeutics, a privately held biopharmaceutical company. Dr. Bloom serves on the Scientific Advisory Boards of aTyr Pharma, Riverest and AgeneBio, Inc., all privately held pharmaceutical companies. Dr. Bloom served as a member of the board of directors of Elan from 2007 to 2009 and serves as an advisor to its Science and Technology Committee.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

6,587,780

Shane Cooke

3,164,580

James Frates

1,831,190

Gordon Pugh

1,965,720

Kathryn Biberstein

2,113,310

Rebecca Peterson

--
As Of 30 Mar 2013
Search Stocks